News From March 2020: Visiopharm and Proscia

Proscia
By Author Proscia | March 30, 2020

Visiopharm and Proscia have entered into a multi-year, strategic partnership to deliver deeply integrated AI-enabled solutions that drive breakthroughs in translational research and advance precision medicine. In addition to joint product integration, Visiopharm and Proscia have established a global reseller and support agreement to accelerate the delivery of these combined offerings to the market.

New to digital pathology? Learn how whole slide imaging is changing the industry here.

Our website uses cookies. By using this site, you agree to its use of cookies.